Lachman has been providing
both onsite and remote
support to our clients
for many years.

Review Support Offerings
The Lachman Difference

The most efficient services.
The most qualified professionals.

Since 1978, Lachman Consultants’ multidisciplinary team of highly experienced FDA consultants and industry experts has offered compliance, regulatory affairs, and science & technology services to clients around the world.

Learn More About Us

Stay in the know

Sign up today for the Lachman Consultants blog.

Get the latest news on industry compliance, regulatory affairs, technical services, and a whole lot more.

    AREAS SERVED BY LACHMAN CONSULTANTS

    ADVANCE. CONFIDENTLY.

    As long-standing leaders in technical and regulatory consulting services, Lachman Consultants provides both experience and excellence through an unmatched team of respected industry professionals and SMEs.

    Mock FDA Inspections

    Are you fully prepared for an inspection at your facility?

    Our team of experienced ex-FDA investigators offer comprehensive mock FDA inspection services to help you prepare for an actual FDA inspection. Our team of experts will conduct a thorough inspection of your facility, review your documentation, and provide you with valuable feedback on areas that need improvement to ensure compliance with FDA regulations – both remotely and on-site.

    Learn More About Mock FDA Inspections

    OnCall Image

    Recent Posts

    The Lachman Consultants Blog

    The latest on industry compliance, regulatory affairs, technical services, and a whole lot more.

    Shot of an asian businessman shouting into a megaphone against a studio background

    Now Hear This!

    Reviewed “under the FDA’s De Novo premarket review pathway, a regu...
    Read More

    Newest Chapter in the Nitrosamine Saga – A Revised Guidance and FDA Acknowledges Their Differences

    The FDA has updated the original nitrosamine impurity guidance after p...
    Read More
    PDA Conference Day 2 - An Overview - Lachman Consultants

    PDA Conference Day 2 – An Overview

    Day 2 of the 2024 PDA/FDA Joint Regulatory Conference kicked off in a...
    Read More
    PDA/FDA Joint Regulatory Conference 2024 - Day 1

    PDA/FDA Joint Regulatory Conference 2024 – Day 1

    It’s been a pleasure to return to the PDA/FDA’s 2024 Joint Regulat...
    Read More
    CAPAs

    Effective CAPAs are the “Root” of Positive Change

    CAPAs are one of the most important elements of the pharmaceutical Qua...
    Read More
    Generic and Biosimilar Savings Report - Lachman Consultants

    Generic and Biosimilar Savings Report for 2024 Issues – Worry on the Horizon?

    With savings continuing to rise, are we at the apex of the climb or sh...
    Read More
    ADVANCE CONFIDENTLY
    Contact Us Today